These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 4570787)

  • 21. An anti-beta-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo.
    Rachini A; Pietrella D; Lupo P; Torosantucci A; Chiani P; Bromuro C; Proietti C; Bistoni F; Cassone A; Vecchiarelli A
    Infect Immun; 2007 Nov; 75(11):5085-94. PubMed ID: 17606600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytochemical and biochemical identification of lysosomes in Cryptococcus neoformans.
    Mason DL; Wilson CL
    Mycopathologia; 1979 Sep; 68(3):183-90. PubMed ID: 394002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cryptococcus neoformans host adaptation: toward biological evidence of dormancy.
    Alanio A; Vernel-Pauillac F; Sturny-Leclère A; Dromer F
    mBio; 2015 Mar; 6(2):. PubMed ID: 25827423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Light microscopy of basidia, basidiospores, and nuclei in spores and hyphae of Filobasidiella neoformans (Cryptococcus neoformans).
    Erke KH
    J Bacteriol; 1976 Oct; 128(1):445-55. PubMed ID: 789347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Morphological variations of a hypha-forming strain of Cryptococcus neoformans (Coward strain) in tissues of mice.
    Lurie HI; Shadomy HJ
    Sabouraudia; 1971 Mar; 9(1):10-4. PubMed ID: 4928767
    [No Abstract]   [Full Text] [Related]  

  • 26. Naïve B cells reduce fungal dissemination in Cryptococcus neoformans infected Rag1
    Dufaud C; Rivera J; Rohatgi S; Pirofski LA
    Virulence; 2018 Jan; 9(1):173-184. PubMed ID: 28837391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colonization and pathogenesis of Cryptococcus neoformans in gnotobiotic mice.
    Salkowski CA; Bartizal KF; Balish MJ; Balish E
    Infect Immun; 1987 Sep; 55(9):2000-5. PubMed ID: 3305359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melanin, melanin "ghosts," and melanin composition in Cryptococcus neoformans.
    Wang Y; Aisen P; Casadevall A
    Infect Immun; 1996 Jul; 64(7):2420-4. PubMed ID: 8698461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Host Carbon Dioxide Concentration Is an Independent Stress for Cryptococcus neoformans That Affects Virulence and Antifungal Susceptibility.
    Krysan DJ; Zhai B; Beattie SR; Misel KM; Wellington M; Lin X
    mBio; 2019 Jul; 10(4):. PubMed ID: 31266878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polysaccharide diversity in VNI isolates of Cryptococcus neoformans from Roraima, Northern Brazil.
    Dal Pupo HD; Sena BAG; Reis FCG; Machado L; Fortes ST; de Almeida Junior JN; Godinho RMC; Rodrigues ML
    Fungal Biol; 2019 Oct; 123(10):699-708. PubMed ID: 31542188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cryptococcus neoformans capsule structure evolution in vitro and during murine infection.
    Garcia-Hermoso D; Dromer F; Janbon G
    Infect Immun; 2004 Jun; 72(6):3359-65. PubMed ID: 15155641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the biological activity of Cryptococcus infections in surgical pathology. The Budding Index and Carminophilic Index.
    Schwartz DA
    Ann Clin Lab Sci; 1988; 18(5):388-97. PubMed ID: 2460017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proven pulmonary cryptococcosis due to capsule-deficient Cryptococcus neoformans does not differ clinically from proven pulmonary cryptococcosis due to capsule-intact Cr. neoformans.
    Torres HA; Prieto VG; Raad II; Kontoyiannis DP
    Mycoses; 2005 Jan; 48(1):21-4. PubMed ID: 15679661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection.
    Feldmesser M; Kress Y; Novikoff P; Casadevall A
    Infect Immun; 2000 Jul; 68(7):4225-37. PubMed ID: 10858240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In Vitro Titan Cell Generation in Cryptococcus neoformans and Automated Cell Size Measurements.
    Hommel B; Sturny-Leclère A; Alanio A
    Methods Mol Biol; 2024; 2775():385-391. PubMed ID: 38758332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Overlooked Glycan Components of the Cryptococcus Capsule.
    Fonseca FL; Reis FCG; Sena BAG; Jozefowicz LJ; Kmetzsch L; Rodrigues ML
    Curr Top Microbiol Immunol; 2019; 422():31-43. PubMed ID: 30203395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical isolates of Cryptococcus neoformans from Zaire.
    Swinne D; Nkurikiyinfura JB; Muyembe TL
    Eur J Clin Microbiol; 1986 Feb; 5(1):50-1. PubMed ID: 3516683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cryptococcus neoformans and Cryptococcus gattii genes preferentially expressed during rat macrophage infection.
    Goulart L; Rosa e Silva LK; Chiapello L; Silveira C; Crestani J; Masih D; Vainstein MH
    Med Mycol; 2010 Nov; 48(7):932-41. PubMed ID: 20302549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The ultrastructure of Cryptococcus neoformans.
    al-Doory Y
    Sabouraudia; 1971 Jul; 9(2):115-8. PubMed ID: 4106826
    [No Abstract]   [Full Text] [Related]  

  • 40. Virulence of Cryptococcus neoformans serotypes A, B, C and D for four mouse strains.
    Irokanulo EA; Akueshi CO
    J Med Microbiol; 1995 Oct; 43(4):289-93. PubMed ID: 7562991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.